Generic Toradol: Akorn-Strides Ketorolac Tromethamine

Akorn-Strides, LLC Announces its First ANDA Approval For Ketorolac Tromethamine Injection USP, 15 mg/mL and 30 mg/mL

Tuesday, July 17, 2007

BUFFALO GROVE, Ill. – Akorn-Strides, LLC today announced its first ANDA approval for Ketorolac Tromethamine Injection USP, 15 mg/mL and 30 mg/mL. Akorn-Strides, LLC is a Joint Venture that was formed in 2005 by Akorn, Inc. and Strides Arcolab Limited. The primary mission for the Joint Venture is developing liquid, lyophilized and dry powder fill generic injectable products targeting several therapeutic markets with a major focus on anti-infectives, analgesics and CNS medicines.

Drug Name(s)KETOROLAC TROMETHAMINE (Generic Drug)
FDA Application No.(ANDA) 078299
Active Ingredient(s)KETOROLAC TROMETHAMINE
CompanyAKORN STRIDES
Original Approval DateJuly 16, 2007